Guru Ownership Trend
Guru Analysis for Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.05 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $683,653.97 net inflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 633.9%. Conversely, Cliff Asness reduced exposure by 29.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Krystal Biotech, Inc. (KRYS)
Major holders include Ken Fisher ($7.18 M), Cliff Asness ($3.49 M), Ray Dalio ($2.47 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 57,934 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $683,653.97, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited KRYS. The total reported sell value was $1.47 M.
Yes, 3 managers opened new positions in KRYS, and 1 increased their existing holdings. The total reported buy value was $2.16 M.